NCT06468566

Brief Summary

Ultrasonic light scattering imaging is a new functional imaging technology that combines traditional B-mode ultrasound imaging and light scattering tomography (DOT). It can improve the accuracy of early diagnosis of breast cancer based on the characteristics of abnormal blood supply and oxygen consumption of lesions. This study aims to evaluate the value of ultrasonic light scattering imaging in the differential diagnosis of benign and malignant breast nodules, and to evaluate the consistency between ultrasonic light scattering imaging and examiners in the differential diagnosis of benign and malignant breast nodules.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 10, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

2 years

First QC Date

June 10, 2024

Last Update Submit

June 16, 2024

Conditions

Keywords

Ultrasonic light scattering imagingBreast CancerMetastasisArtificial intelligence

Outcome Measures

Primary Outcomes (4)

  • Benign breast tumor

    Pathological diagnosis

    Up to 12 months

  • Malignant breast tumor

    Pathological diagnosis

    Up to 12 months

  • Breast lymph node metastasis

    Pathological diagnosis

    Up to 12 months

  • No lymph node metastasis

    Pathological diagnosis

    Up to 12 months

Study Arms (3)

Whether to use ultrasound light scattering imaging equipment

Diagnostic Test: Ultrasound light scattering imaging equipment

Conventional ultrasound

Device Assistant physician

Diagnostic Test: Ultrasound light scattering imaging equipment

Interventions

Radiologists use ultrasound light scattering imaging to evaluate the benign and malignant nature of breast nodules

Device Assistant physicianWhether to use ultrasound light scattering imaging equipment

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In order to verify that ultrasound light scattering imaging technology can help in the differential diagnosis of benign and malignant breast nodules. For subjects who meet the inclusion criteria, breast nodules will be examined by traditional ultrasound and ultrasonic light scattering imaging, and the diagnostic efficacy of both will be determined based on the final pathological results of the subjects.

You may qualify if:

  • Had breast lesions detected by ultrasound Age 18 or older Upcoming FNAB or surgery Signing informed consent

You may not qualify if:

  • Patients who had received a biopsy of breast lesion before the ultrasound examination Can not cooperate with the test operation Patients who were pregnant or lactating Patients who were undergoing neoadjuvant treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xin-Wu Cui

Wuhan, Hubei, 430030, China

RECRUITING

Related Publications (3)

  • Huang Y, Cua M, Brake J, Liu Y, Yang C. Investigating ultrasound-light interaction in scattering media. J Biomed Opt. 2020 Feb;25(2):1-12. doi: 10.1117/1.JBO.25.2.025002.

    PMID: 32103649BACKGROUND
  • Di Sciacca G, Maffeis G, Farina A, Dalla Mora A, Pifferi A, Taroni P, Arridge S. Evaluation of a pipeline for simulation, reconstruction, and classification in ultrasound-aided diffuse optical tomography of breast tumors. J Biomed Opt. 2022 Mar;27(3):036003. doi: 10.1117/1.JBO.27.3.036003.

    PMID: 35332743BACKGROUND
  • Zhu Q, Ricci A Jr, Hegde P, Kane M, Cronin E, Merkulov A, Xu Y, Tavakoli B, Tannenbaum S. Assessment of Functional Differences in Malignant and Benign Breast Lesions and Improvement of Diagnostic Accuracy by Using US-guided Diffuse Optical Tomography in Conjunction with Conventional US. Radiology. 2016 Aug;280(2):387-97. doi: 10.1148/radiol.2016151097. Epub 2016 Mar 2.

    PMID: 26937708BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsNeoplasm Metastasis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Xiao-Feng Zhang, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 21, 2024

Study Start

February 1, 2024

Primary Completion

January 30, 2026

Study Completion

February 28, 2026

Last Updated

June 21, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations